April 2, 2024

HP Inc. Share Price Target ‘$31.85’, now 5.4% Upside Potential

HP Inc. which can be found using ticker (HPQ) now have 13 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges..

Dell Technologies Inc. Share Price Target ‘$122.62’, now 7.5% Upside Potential

Dell Technologies Inc. with ticker code (DELL) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $144.00..

Gartner, Inc. Share Price Target ‘$489.13’, now 2.6% Upside Potential

Gartner, Inc. with ticker code (IT) now have 8 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and..

Block, Inc. Share Price Target ‘$89.18’, now 5.4% Upside Potential

Block, Inc. with ticker code (SQ) have now 39 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $110.00 and..

Splunk Inc. Share Price Target ‘$150.36’, now -4.2% Downside Potential

Splunk Inc. with ticker code (SPLK) have now 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $162.00 and..

HubSpot, Inc. Share Price Target ‘$697.15’, now 11.3% Upside Potential

HubSpot, Inc. with ticker code (HUBS) have now 26 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $800.00 and..

Uber Technologies, Inc. Share Price Target ‘$86.19’, now 11.9% Upside Potential

Uber Technologies, Inc. with ticker code (UBER) have now 44 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges..

Super Micro Computer, Inc. Share Price Target ‘$914.66’, now -9.4% Downside Potential

Super Micro Computer, Inc. which can be found using ticker (SMCI) now have 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The..

Skyworks Solutions, Inc. Share Price Target ‘$115.06’, now 6.2% Upside Potential

Skyworks Solutions, Inc. with ticker code (SWKS) have now 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $154.00..

Palantir Technologies Inc. Share Price Target ‘$20.21’, now -12.2% Downside Potential

Palantir Technologies Inc. with ticker code (PLTR) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $35.00..

Workday, Inc. Share Price Target ‘$317.73’, now 16.5% Upside Potential

Workday, Inc. with ticker code (WDAY) now have 33 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and..

Intel Corporation Share Price Target ‘$44.97’, now 1.8% Upside Potential

Intel Corporation which can be found using ticker (INTC) have now 37 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The target price..

Time Finance positive trading update with CEO Ed Rimmer (VIDEO)

Time Finance plc CEO Ed Rimmer discusses the company's positive performance in a trading update. Learn about the key drivers and future aspirations here...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...

Strix Group welcomes Clare Foster as new CFO

Learn about the latest appointment at Strix Group Plc as Clare Foster joins as Chief Financial Officer, succeeding Mark Kirkland who remains a Non-Executive Director...

Cizzle Biotechnology signs Exclusive Licensing Agreement for lung cancer biomarker test

Cizzle Biotechnology Holdings plc signs exclusive licensing agreement to develop lung cancer diagnostic test in USA and Canada. Exciting partnership ahead!..
Search

Funds

April 2, 2024

Time Finance positive trading update with CEO Ed Rimmer (VIDEO)

Time Finance plc CEO Ed Rimmer discusses the company's positive performance in a trading update. Learn about the key drivers and future aspirations here...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...

Strix Group welcomes Clare Foster as new CFO

Learn about the latest appointment at Strix Group Plc as Clare Foster joins as Chief Financial Officer, succeeding Mark Kirkland who remains a Non-Executive Director...

Cizzle Biotechnology signs Exclusive Licensing Agreement for lung cancer biomarker test

Cizzle Biotechnology Holdings plc signs exclusive licensing agreement to develop lung cancer diagnostic test in USA and Canada. Exciting partnership ahead!..
Search

Funds

April 2, 2024

FTSE 100

Funds